Skip to main content
Erschienen in: Inflammation 3/2010

01.06.2010

Cellular and Molecular Characterization of Ozone-Induced Pulmonary Inflammation in the Cynomolgus Monkey

verfasst von: Alexandra Hicks, Galina Kourteva, Holly Hilton, Hongli Li, Tai-An Lin, Will Liao, Ying Li, Xin Wei, Thomas March, Janet Benson, Louis M. Renzetti

Erschienen in: Inflammation | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

We investigated the cellular and molecular effects of ozone exposure in Cynomolgus monkeys. Thirty-six Cynomolgus monkeys were exposed to single or repeat ozone challenge. Pulmonary inflammation was assessed using bronchoalveolar lavage fluid (BAL) and histology. Gene expression profiling in lung and blood was performed. Ozone challenge evoked BAL cellular inflammation and increases in total protein, alkaline phosphatase and cytokines. Lung histology revealed cellular inflammation and epithelial necrosis. Gene expression profiling identified oxidative phosphorylation, immune response and cell adhesion pathways altered in response to ozone, with common and unique profiles in lung and blood. Lipocalin 2, CD177, the FK-506 and S100A8 binding proteins and ST-2 represent novel peripheral biomarkers of ozone toxicity. Repeat ozone challenge evoked reproducible inflammation but attenuated cell damage. These studies provide data on the molecular mechanisms and biomarker identification of ozone-evoked toxicity, and support the use of the Cynomolgus monkey as a model of human ozone challenge.
Literatur
1.
Zurück zum Zitat MacNee, W., and K. Donaldson. 2000. Exacerbations of COPD: Environmental mechanisms. Chest 117: 390S–379S.CrossRefPubMed MacNee, W., and K. Donaldson. 2000. Exacerbations of COPD: Environmental mechanisms. Chest 117: 390S–379S.CrossRefPubMed
2.
Zurück zum Zitat Jorres, R.A., O. Holz, W. Zachgo, P. Timm, S. Koschyk, B. Muller, F. Grimminger, W. Seeger, F.J. Kelly, C. Dunster, T. Frischer, G. Lubec, M. Waschewski, A. Niendorf, and H. Magnussen. 2000. The effect of repeated ozone exposures on inflammatory markers in bronchoalveolar lavage fluid and mucosal biopsies. American Journal of Respiratory and Critical Care Medicine 161: 1855–1861.PubMed Jorres, R.A., O. Holz, W. Zachgo, P. Timm, S. Koschyk, B. Muller, F. Grimminger, W. Seeger, F.J. Kelly, C. Dunster, T. Frischer, G. Lubec, M. Waschewski, A. Niendorf, and H. Magnussen. 2000. The effect of repeated ozone exposures on inflammatory markers in bronchoalveolar lavage fluid and mucosal biopsies. American Journal of Respiratory and Critical Care Medicine 161: 1855–1861.PubMed
3.
Zurück zum Zitat Sterner-Kock, A., M. Kock, R. Braun, and D.M. Hyde. 2000. Ozone-induced epithelial injury in the ferret is similar to nonhuman primates. American Journal of Respiratory and Critical Care Medicine 162: 1152–1156.PubMed Sterner-Kock, A., M. Kock, R. Braun, and D.M. Hyde. 2000. Ozone-induced epithelial injury in the ferret is similar to nonhuman primates. American Journal of Respiratory and Critical Care Medicine 162: 1152–1156.PubMed
4.
Zurück zum Zitat Holz, O., R. Tal-Singer, F. Kanniess, K.J. Simpson, A. Gibson, R.S.J. Vessey, S. Janicki, H. Magnussen, R.A. Jorres, K. Richter, O. Holz, R. Tal-Singer, F. Kanniess, K.J. Simpson, A. Gibson, and R.S.J. Vessey. 2005. Validation of the human ozone challenge model as a tool for assessing anti-inflammatory drugs in early development. Journal of Clinical Pharmacology 45: 498–503.CrossRefPubMed Holz, O., R. Tal-Singer, F. Kanniess, K.J. Simpson, A. Gibson, R.S.J. Vessey, S. Janicki, H. Magnussen, R.A. Jorres, K. Richter, O. Holz, R. Tal-Singer, F. Kanniess, K.J. Simpson, A. Gibson, and R.S.J. Vessey. 2005. Validation of the human ozone challenge model as a tool for assessing anti-inflammatory drugs in early development. Journal of Clinical Pharmacology 45: 498–503.CrossRefPubMed
5.
Zurück zum Zitat Seltzer, J., B.G. Bigby, M. Stulbarg, M.J. Holtzman, J.A. Nadel, I.F. Ueki, G.D. Leikauf, E.J. Goetz, and H.A. Boushey. 1986. O3-induced change in bronchial reactivity to methacholine and airway inflammation in humans. Journal of Applied Physiology 60: 1321–1326.PubMed Seltzer, J., B.G. Bigby, M. Stulbarg, M.J. Holtzman, J.A. Nadel, I.F. Ueki, G.D. Leikauf, E.J. Goetz, and H.A. Boushey. 1986. O3-induced change in bronchial reactivity to methacholine and airway inflammation in humans. Journal of Applied Physiology 60: 1321–1326.PubMed
6.
Zurück zum Zitat Schelegle, E.S., W.F. Walby, M.F. Alfaro, V.J. Wong, L. Putney, M.Y. Stovall, A. Sterner-Kock, D.M. Hyde, and C.G. Plopper. 2003. Repeated episodes of ozone inhalation attenuates airway injury/repair and release of substance P, but not adaptation. Toxicology and Applied Pharmacology 186: 127–142.CrossRefPubMed Schelegle, E.S., W.F. Walby, M.F. Alfaro, V.J. Wong, L. Putney, M.Y. Stovall, A. Sterner-Kock, D.M. Hyde, and C.G. Plopper. 2003. Repeated episodes of ozone inhalation attenuates airway injury/repair and release of substance P, but not adaptation. Toxicology and Applied Pharmacology 186: 127–142.CrossRefPubMed
7.
Zurück zum Zitat Kanniess, F., S. Khalilieh, A. Ludwig-Sengpiel, P. Stryszak, P. Soni, O. Holz, and H. Magnussen. 2007. SCH 527123, a CXCR2 antagonist, inhibits ozone-induced airway neutrophilia in healthy subjects. European Respiratory Journal 51: 209S. Kanniess, F., S. Khalilieh, A. Ludwig-Sengpiel, P. Stryszak, P. Soni, O. Holz, and H. Magnussen. 2007. SCH 527123, a CXCR2 antagonist, inhibits ozone-induced airway neutrophilia in healthy subjects. European Respiratory Journal 51: 209S.
8.
Zurück zum Zitat Plopper, C.G., and D.M. Hyde. 2008. The non-human primate as a model for studying COPD and asthma. Pulmonary Pharmacology & Therapeutics 21: 755–766.CrossRef Plopper, C.G., and D.M. Hyde. 2008. The non-human primate as a model for studying COPD and asthma. Pulmonary Pharmacology & Therapeutics 21: 755–766.CrossRef
9.
Zurück zum Zitat Hicks, A., J. Benson, T. March, and L. Renzetti. 2007. Ozone inhalation produces reproducible lung inflammation in the Cynomolgus monkey. European Respiratory Journal 51: 134S. Hicks, A., J. Benson, T. March, and L. Renzetti. 2007. Ozone inhalation produces reproducible lung inflammation in the Cynomolgus monkey. European Respiratory Journal 51: 134S.
10.
Zurück zum Zitat Kourteva, G., H. Hilton, X. Wei, Y.L. Li, T. March, J. Benson, J.A. Rosinski, and A. Hicks. 2008. Lung and blood gene expression profiles from Cynomolgus monkeys exposed to ozone. FASEB Journal 22: lb212. Kourteva, G., H. Hilton, X. Wei, Y.L. Li, T. March, J. Benson, J.A. Rosinski, and A. Hicks. 2008. Lung and blood gene expression profiles from Cynomolgus monkeys exposed to ozone. FASEB Journal 22: lb212.
11.
Zurück zum Zitat Gentleman, R., V.J. Carey, and W. Huber. 2005. Bioinformatics and computational biology solutions using R and bioconductor. (Statistics for Biology and Health). Springer. Gentleman, R., V.J. Carey, and W. Huber. 2005. Bioinformatics and computational biology solutions using R and bioconductor. (Statistics for Biology and Health). Springer.
12.
Zurück zum Zitat Krishna, M.T., J. Madden, L.M. Teran, G.L. Biscione, L.C.K. Lau, N.J. Withers, T. Sandstrom, I. Mudway, F.J. Kelly, A. Walls, A.J. Frew, and S.T. Holgate. 1998. Effects of 0.2 ppm ozone on biomarkers of inflammation in bronchoalveolar lavage fluid and bronchial mucosa of healthy subjects. European Respiratory Journal 11: 1294–1300.CrossRefPubMed Krishna, M.T., J. Madden, L.M. Teran, G.L. Biscione, L.C.K. Lau, N.J. Withers, T. Sandstrom, I. Mudway, F.J. Kelly, A. Walls, A.J. Frew, and S.T. Holgate. 1998. Effects of 0.2 ppm ozone on biomarkers of inflammation in bronchoalveolar lavage fluid and bronchial mucosa of healthy subjects. European Respiratory Journal 11: 1294–1300.CrossRefPubMed
13.
Zurück zum Zitat Kooter, I.M., J.L.A. Pennings, P.H.B. Fokkens, D.L.A.C. Leseman, A.J.F. Boere, M.E. Gerlofs-Nijland, F.R. Cassee, J.A.C. Schalk, T.J.H. Orzechowski, M.M. Schaap, T.M. Breit, J.A.M.A. Dormans, C.T.M. van Oostrom, A. de Vries, and H. van Steeg. 2007. Ozone induces clear cellular and molecular responses in the mouse lung independently of the transcription-coupled repair status. Journal of Applied Physiology 102: 1185–1192.CrossRefPubMed Kooter, I.M., J.L.A. Pennings, P.H.B. Fokkens, D.L.A.C. Leseman, A.J.F. Boere, M.E. Gerlofs-Nijland, F.R. Cassee, J.A.C. Schalk, T.J.H. Orzechowski, M.M. Schaap, T.M. Breit, J.A.M.A. Dormans, C.T.M. van Oostrom, A. de Vries, and H. van Steeg. 2007. Ozone induces clear cellular and molecular responses in the mouse lung independently of the transcription-coupled repair status. Journal of Applied Physiology 102: 1185–1192.CrossRefPubMed
14.
Zurück zum Zitat Chang, M.M., R. Wu, C.G. Plopper, and D.M. Hyde. 1998. IL-8 is one of the major chemokines produced by monkey airway epithelium after ozone-induced injury. American Journal of Physiology 275: L524–L532.PubMed Chang, M.M., R. Wu, C.G. Plopper, and D.M. Hyde. 1998. IL-8 is one of the major chemokines produced by monkey airway epithelium after ozone-induced injury. American Journal of Physiology 275: L524–L532.PubMed
15.
Zurück zum Zitat Johnston, R.A., J.P. Mizgerd, and S.A. Shore. 2005. CXCR2 is essential for maximal neutrophil recruitment and methacholine responsiveness after ozone exposure. American Journal of Physiology. Lung Cellular and Molecular Physiology 288: L61–L67.CrossRefPubMed Johnston, R.A., J.P. Mizgerd, and S.A. Shore. 2005. CXCR2 is essential for maximal neutrophil recruitment and methacholine responsiveness after ozone exposure. American Journal of Physiology. Lung Cellular and Molecular Physiology 288: L61–L67.CrossRefPubMed
16.
Zurück zum Zitat Yu, M., X. Zheng, H. Witschi, and K.E. Pinkerton. 2002. The role of interleukin 6 in pulmonary inflammation and injury induced by exposure to environmental air pollutants. Tox Sci 68: 488–497.CrossRef Yu, M., X. Zheng, H. Witschi, and K.E. Pinkerton. 2002. The role of interleukin 6 in pulmonary inflammation and injury induced by exposure to environmental air pollutants. Tox Sci 68: 488–497.CrossRef
17.
Zurück zum Zitat Kierstein, S., F.R. Poulain, Y. Cao, M. Grous, R. Mathias, G. Kierstein, M.F. Beers, M. Salmon, R.A. Panettieri Jr., and A. Haczku. 2006. Susceptibility to ozone-induced airway inflammation is associated with decreased levels of surfactant protein D. Respiratory Research 7: 85–94.CrossRefPubMed Kierstein, S., F.R. Poulain, Y. Cao, M. Grous, R. Mathias, G. Kierstein, M.F. Beers, M. Salmon, R.A. Panettieri Jr., and A. Haczku. 2006. Susceptibility to ozone-induced airway inflammation is associated with decreased levels of surfactant protein D. Respiratory Research 7: 85–94.CrossRefPubMed
18.
Zurück zum Zitat Kierstein, S., K. Krytska, S. Sharma, Y. Amrani, M. Salmon, R.A. Panettieri Jr., J. Zangrilli, and A. Haczku. 2008. Ozone inhalation induces exacerbation of eosinophilic airway inflammation and hyperresponsiveness in allergen-sensitized mice. Allergy 63: 438–446.CrossRefPubMed Kierstein, S., K. Krytska, S. Sharma, Y. Amrani, M. Salmon, R.A. Panettieri Jr., J. Zangrilli, and A. Haczku. 2008. Ozone inhalation induces exacerbation of eosinophilic airway inflammation and hyperresponsiveness in allergen-sensitized mice. Allergy 63: 438–446.CrossRefPubMed
19.
Zurück zum Zitat Potter-Perigo, S., E.D. Kaplan, D.L. Luchtel, C. Baker, L.C. Altman, and T.N. Wight. 1998. Ozone alters the expression of tenascin-C in cultured primate nasal epithelial cells. American Journal of Respiratory Cell and Molecular Biology 18: 471–478.PubMed Potter-Perigo, S., E.D. Kaplan, D.L. Luchtel, C. Baker, L.C. Altman, and T.N. Wight. 1998. Ozone alters the expression of tenascin-C in cultured primate nasal epithelial cells. American Journal of Respiratory Cell and Molecular Biology 18: 471–478.PubMed
20.
Zurück zum Zitat Hoshino, M., S. Morita, H. Iwashita, Y. Sagiya, T. Nagi, A. Nakanishi, Y. Ashida, O. Nishimura, Y. Fujisawa, and M. Fujino. 2002. Increased expression of the human Ca2+-activates Cl− channel 1 (CaCC1) gene in the asthmatic airway. American Journal of Respiratory and Critical Care Medicine 165(8): 1132–1138.PubMed Hoshino, M., S. Morita, H. Iwashita, Y. Sagiya, T. Nagi, A. Nakanishi, Y. Ashida, O. Nishimura, Y. Fujisawa, and M. Fujino. 2002. Increased expression of the human Ca2+-activates Cl channel 1 (CaCC1) gene in the asthmatic airway. American Journal of Respiratory and Critical Care Medicine 165(8): 1132–1138.PubMed
21.
Zurück zum Zitat Hauber, H.P., C. Bergeron, A. Tsicopoulos, B. Wallaert, R. Olivenstein, K.J. Holroyd, R.C. Levitt, and Q. Hamid. 2005. Increased expression of the calcium-activated chloride channel hCLCA1 in airways of patients with obstructive chronic bronchitis. Canadian Respiratory Journal 12(3): 143–146.PubMed Hauber, H.P., C. Bergeron, A. Tsicopoulos, B. Wallaert, R. Olivenstein, K.J. Holroyd, R.C. Levitt, and Q. Hamid. 2005. Increased expression of the calcium-activated chloride channel hCLCA1 in airways of patients with obstructive chronic bronchitis. Canadian Respiratory Journal 12(3): 143–146.PubMed
22.
Zurück zum Zitat Williams, A.S., R. Issa, S.Y. Leung, P. Nath, G.D. Ferguson, B.L. Bennett, I.M. Adcock, and K.F. Chung. 2007. Attenuation of ozone-induced airway inflammation and hyper-responsiveness by c-jun NH2 terminal kinase inhibitor SP600125. Journal of Pharmacology and Experimental Therapeutics 322: 351–359.CrossRefPubMed Williams, A.S., R. Issa, S.Y. Leung, P. Nath, G.D. Ferguson, B.L. Bennett, I.M. Adcock, and K.F. Chung. 2007. Attenuation of ozone-induced airway inflammation and hyper-responsiveness by c-jun NH2 terminal kinase inhibitor SP600125. Journal of Pharmacology and Experimental Therapeutics 322: 351–359.CrossRefPubMed
23.
Zurück zum Zitat Lim, S.Y., M. Raftery, H. Cai, K. Hsu, W.X. Yan, H.L. Hseih, R.N. Watts, D. Richardson, S. Thomas, M. Perry, and C.L. Geczy. 2008. S-Nitrosylated S100A8: Novel anti-inflammatory properties. Journal of Immunology 181: 5627–5636. Lim, S.Y., M. Raftery, H. Cai, K. Hsu, W.X. Yan, H.L. Hseih, R.N. Watts, D. Richardson, S. Thomas, M. Perry, and C.L. Geczy. 2008. S-Nitrosylated S100A8: Novel anti-inflammatory properties. Journal of Immunology 181: 5627–5636.
24.
Zurück zum Zitat Arend, W.P., G. Palmer, and C. Gabay. 2008. IL-1, IL-18, and IL-33 families of cytokines. Immunological Reviews 223: 20–38.CrossRefPubMed Arend, W.P., G. Palmer, and C. Gabay. 2008. IL-1, IL-18, and IL-33 families of cytokines. Immunological Reviews 223: 20–38.CrossRefPubMed
25.
Zurück zum Zitat Sunhil, V.R., K.J. Patel, M. Nilsen-Hamilton, D.E. Heck, J.D. Laskin, and D.L. Laskin. 2007. Acute endotoxemia is associated with upregulation of lipocalin 24p3/Lcn2 in lung and liver. Experimental and Molecular Pathology 83: 177–187.CrossRef Sunhil, V.R., K.J. Patel, M. Nilsen-Hamilton, D.E. Heck, J.D. Laskin, and D.L. Laskin. 2007. Acute endotoxemia is associated with upregulation of lipocalin 24p3/Lcn2 in lung and liver. Experimental and Molecular Pathology 83: 177–187.CrossRef
26.
Zurück zum Zitat Andre, E., T. Stoeger, S. Takenaka, M. Bahnweg, B. Ritter, E. Karg, B. Lentner, C. Reinhard, H. Schulz, and M. Wjst. 2006. Inhalation of ultrafine carbon particles triggers biphasic pro-inflammatory response in the mouse lung. European Respiratory Journal 28: 275–285.CrossRefPubMed Andre, E., T. Stoeger, S. Takenaka, M. Bahnweg, B. Ritter, E. Karg, B. Lentner, C. Reinhard, H. Schulz, and M. Wjst. 2006. Inhalation of ultrafine carbon particles triggers biphasic pro-inflammatory response in the mouse lung. European Respiratory Journal 28: 275–285.CrossRefPubMed
27.
Zurück zum Zitat Keatings, V.M., and P.J. Barnes. 1997. Granulocyte activation markers in induced sputum: Comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. American Journal of Respiratory and Critical Care Medicine 155(2): 449–453.PubMed Keatings, V.M., and P.J. Barnes. 1997. Granulocyte activation markers in induced sputum: Comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. American Journal of Respiratory and Critical Care Medicine 155(2): 449–453.PubMed
28.
Zurück zum Zitat Sachs, U.J.H., C.L. Andrei-Selmer, A. Maniar, T. Weiss, C. Paddock, V.V. Orlova, E.Y. Choi, P.J. Newman, K.T. Preissner, T. Chavakis, and S. Santoso. 2007. The neutrophil-specific antigen CD177 is a counter-receptor for platelet endothelial cell adhesion molecule-1 (CD31). Journal of Biological Chemistry 282(32): 23603–23612.CrossRefPubMed Sachs, U.J.H., C.L. Andrei-Selmer, A. Maniar, T. Weiss, C. Paddock, V.V. Orlova, E.Y. Choi, P.J. Newman, K.T. Preissner, T. Chavakis, and S. Santoso. 2007. The neutrophil-specific antigen CD177 is a counter-receptor for platelet endothelial cell adhesion molecule-1 (CD31). Journal of Biological Chemistry 282(32): 23603–23612.CrossRefPubMed
29.
Zurück zum Zitat Sun, J., and K.F. Chung. 1997. Airway inflammation despite loss of bronchial hyperresponsiveness after multiple ozone exposures. Respiratory Medicine 91: 47–55.CrossRefPubMed Sun, J., and K.F. Chung. 1997. Airway inflammation despite loss of bronchial hyperresponsiveness after multiple ozone exposures. Respiratory Medicine 91: 47–55.CrossRefPubMed
30.
Zurück zum Zitat van Bree, L., J.A.M.A. Dormans, H.S. Koren, R.B. Devlin, and P.J.A. Rombout. 2002. Attenuation and recovery of pulmonary injury in rats following short-term, repeated daily exposure to ozone. Inhalation Toxicology 14: 883–900.CrossRefPubMed van Bree, L., J.A.M.A. Dormans, H.S. Koren, R.B. Devlin, and P.J.A. Rombout. 2002. Attenuation and recovery of pulmonary injury in rats following short-term, repeated daily exposure to ozone. Inhalation Toxicology 14: 883–900.CrossRefPubMed
31.
Zurück zum Zitat Tepper, J.S., D.L. Costa, J.R. Lehmann, M.F. Weber, and G.E. Hatch. 1989. Unattenuated structural and biochemical alterations in the rat lung during functional adaptation to ozone. American Review of Respiratory Disease 140: 493–501.PubMed Tepper, J.S., D.L. Costa, J.R. Lehmann, M.F. Weber, and G.E. Hatch. 1989. Unattenuated structural and biochemical alterations in the rat lung during functional adaptation to ozone. American Review of Respiratory Disease 140: 493–501.PubMed
32.
Zurück zum Zitat Devlin, R.B., L.J. Folinsbee, F. Biscardi, G. Hatch, S. Becker, M.C. Madden, M. Robbins, and S.H. Koren. 1997. Inflammation and cell damage induced by repeated exposure of humans to ozone. Inhalation Toxicology 9: 211–235.CrossRef Devlin, R.B., L.J. Folinsbee, F. Biscardi, G. Hatch, S. Becker, M.C. Madden, M. Robbins, and S.H. Koren. 1997. Inflammation and cell damage induced by repeated exposure of humans to ozone. Inhalation Toxicology 9: 211–235.CrossRef
33.
Zurück zum Zitat Barnes, P.J., B. Chowdhury, S.A. Kharitonov, H. Magnussen, C.P. Page, D. Postma, and M. Saetta. 2006. Pulmonary biomarkers in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 174: 6–14.CrossRefPubMed Barnes, P.J., B. Chowdhury, S.A. Kharitonov, H. Magnussen, C.P. Page, D. Postma, and M. Saetta. 2006. Pulmonary biomarkers in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 174: 6–14.CrossRefPubMed
34.
Zurück zum Zitat Wang, I.M., S. Stepaniants, Y. Boie, J.R. Mortimer, B. Kennedy, M. Elliott, S. Hayashi, L. Loy, S. Coulter, S. Cervino, J. Harris, M. Thornton, R. Raubertas, C. Roberts, J.C. Hogg, M. Crackower, G. O’Neill, and P.D. Paré. 2008. Gene expression profiling in patients with chronic obstructive pulmonary disease and lung cancer. American Journal of Respiratory and Critical Care Medicine 177: 402–411.CrossRefPubMed Wang, I.M., S. Stepaniants, Y. Boie, J.R. Mortimer, B. Kennedy, M. Elliott, S. Hayashi, L. Loy, S. Coulter, S. Cervino, J. Harris, M. Thornton, R. Raubertas, C. Roberts, J.C. Hogg, M. Crackower, G. O’Neill, and P.D. Paré. 2008. Gene expression profiling in patients with chronic obstructive pulmonary disease and lung cancer. American Journal of Respiratory and Critical Care Medicine 177: 402–411.CrossRefPubMed
35.
Zurück zum Zitat Di Stefano, A., G. Caramori, F.L. Ricciardolo, A. Capelli, I.M. Adcock, and C.F. Donner. 2004. Cellular and molecular mechanisms in chronic obstructive pulmonary disease: An overview. Clinical and Experimental Allergy 34: 1156–1167.CrossRefPubMed Di Stefano, A., G. Caramori, F.L. Ricciardolo, A. Capelli, I.M. Adcock, and C.F. Donner. 2004. Cellular and molecular mechanisms in chronic obstructive pulmonary disease: An overview. Clinical and Experimental Allergy 34: 1156–1167.CrossRefPubMed
Metadaten
Titel
Cellular and Molecular Characterization of Ozone-Induced Pulmonary Inflammation in the Cynomolgus Monkey
verfasst von
Alexandra Hicks
Galina Kourteva
Holly Hilton
Hongli Li
Tai-An Lin
Will Liao
Ying Li
Xin Wei
Thomas March
Janet Benson
Louis M. Renzetti
Publikationsdatum
01.06.2010
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 3/2010
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-009-9168-5

Weitere Artikel der Ausgabe 3/2010

Inflammation 3/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.